list of glp 1 agonists Injectable GLP-1 Receptor top glp 1 drug companies

Tirzepatide: The Dual Agonist Tirzepatide is often referred to as the next generation GLP-1 because it targets two hormones : This dual mechanism seems to amplify its effects

While originally developed for type 2 diabetes, these medications are now frontline treatments for chronic weight management

57 Phase 1b trial of GSBR-1290 (590 mg) in 24 healthy volunteers over 4 weeks demonstrated no study discontinuations due to AEs

Medication Interactions: If you are already taking insulin or other diabetes medications, the risk of hypoglycemia (low blood sugar) increases

[6] Tirzepatide (Mounjaro): up to 15 mg once weekly for type 2 diabetes, and up to 15 mg once weekly for chronic weight management (marketed as Tirzepatide)